Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05457127 · ClinicalTrials.gov registry record · NA
Obstructive Sleep Apnea Treatment in Serious Mental Illness
A NA study, sponsored by University of California, San Diego.
- Not yet
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT05457127 is a NA study that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 300 participants.
The verdict
NCT05457127, a NA study, has not yet begun recruiting, sponsored by University of California, San Diego.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
Serious mental illnesses (SMI) like schizophrenia and bipolar disorder are two of the most disabling and costly chronic illnesses worldwide. A high proportion of adults with schizophrenia and bipolar disorder have sleep disorders, like obstructive sleep apnea (OSA), but tend to be underdiagnosed and undertreated compared to the general population. This study aims to examine feasibility, acceptance, and impact of OSA treatment and how it affects cognitive function in people with SMI.
Interventions
- DEVICE Automatic Positive Airway Pressure (APAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05457127
The ClinicalTrials.gov registry entry for NCT05457127 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automatic Positive Airway Pressure (APAP) is the first listed.
NCT05457127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05457127 about?
NCT05457127 is a clinical study titled "Obstructive Sleep Apnea Treatment in Serious Mental Illness". Serious mental illnesses (SMI) like schizophrenia and bipolar disorder are two of the most disabling and costly chronic illnesses worldwide. A high proportion of adults with schizophrenia and bipolar disorder have sleep disorders, like obstructive sleep apnea (OSA), but tend to be underdiagnosed and...
What is the current status of trial NCT05457127?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-01-01. Estimated completion is 2026-11.
What interventions are being tested in trial NCT05457127?
The interventions under investigation include: Automatic Positive Airway Pressure (APAP) (DEVICE).
Who is sponsoring clinical trial NCT05457127?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.